Hemangiosarcoma is a rapidly fatal cancer affecting primarily older large breed dogs, requiring compassionate management and honest prognosis conversations.
Hemangiosarcoma creates a distinctive welfare challenge: a disease that causes sudden, often catastrophic crisis events in dogs who may appear well in the intervals between them. The presentation of splenic hemangiosarcoma as acute internal bleeding collapse means some dogs die without prior diagnosis, while those who survive emergency surgery face a prognosis that makes quality-of-life planning essential. The welfare decision about pursuing surgery and chemotherapy versus palliative management versus immediate euthanasia at diagnosis requires honest discussion of the limited time surgery provides and the welfare cost of the recovery period. Dogs who are living well in the interval period between bleeds may genuinely be enjoying life. The welfare imperative is ensuring pain management, monitoring for evidence of suffering, and being prepared to make euthanasia decisions quickly when quality of life deteriorates.